Acorah Software Products - Accounts Production 16.3.350 false true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 NI664179 Prof David Gonzalez De Castro Mr William Moore Mr Ignacio Ribate iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure NI664179 2023-12-31 NI664179 2024-12-31 NI664179 2024-01-01 2024-12-31 NI664179 frs-core:CurrentFinancialInstruments 2024-12-31 NI664179 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 NI664179 frs-core:OtherResidualIntangibleAssets 2024-12-31 NI664179 frs-core:OtherResidualIntangibleAssets 2024-01-01 2024-12-31 NI664179 frs-core:OtherResidualIntangibleAssets 2023-12-31 NI664179 frs-core:SharePremium 2024-12-31 NI664179 frs-core:ShareCapital 2024-12-31 NI664179 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 NI664179 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 NI664179 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 NI664179 frs-bus:SmallEntities 2024-01-01 2024-12-31 NI664179 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 NI664179 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 NI664179 frs-bus:Director1 2024-01-01 2024-12-31 NI664179 frs-bus:Director2 2024-01-01 2024-12-31 NI664179 frs-bus:Director3 2024-01-01 2024-12-31 NI664179 frs-countries:NorthernIreland 2024-01-01 2024-12-31 NI664179 2022-12-31 NI664179 2023-12-31 NI664179 2023-01-01 2023-12-31 NI664179 frs-core:CurrentFinancialInstruments 2023-12-31 NI664179 frs-core:SharePremium 2023-12-31 NI664179 frs-core:ShareCapital 2023-12-31 NI664179 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: NI664179
Univ8 Genomics Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2024
Gray + Press Accountants
21 Old Channel Road
Unit 4A Channel Wharf
Belfast
Antrim
BT3 9DE
Contents
Page
Statement of Financial Position 1—2
Notes to the Financial Statements 3—4
Page 1
Statement of Financial Position
Registered number: NI664179
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 13,781 16,645
13,781 16,645
CURRENT ASSETS
Stocks 5 51,201 15,435
Debtors 6 37,261 5,651
Cash at bank and in hand 215,659 155,980
304,121 177,066
Creditors: Amounts Falling Due Within One Year 7 (86,343 ) (35,180 )
NET CURRENT ASSETS (LIABILITIES) 217,778 141,886
TOTAL ASSETS LESS CURRENT LIABILITIES 231,559 158,531
NET ASSETS 231,559 158,531
CAPITAL AND RESERVES
Called up share capital 2 2
Share premium account 111,191 131,347
Income Statement 120,366 27,182
SHAREHOLDERS' FUNDS 231,559 158,531
Page 1
Page 2
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
The financial statements were approved by the board of directors on 25 July 2025 and were signed on its behalf by:
Prof David Gonzalez De Castro
Director
25/07/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Univ8 Genomics Ltd is a private company, limited by shares, incorporated in Northern Ireland, registered number NI664179 . The registered office is 63 University Road, Belfast, BT7 1NF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
2.2. Turnover
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account. Amortisation is charged at both 10% and 20% straight line depending on the nature of the intangible.
2.4. Stocks and Work in Progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss.
Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.5. Foreign Currencies
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.6. Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
3. Average Number of Employees
Average number of employees during the year was: 1 (2023: 1)
1 1
Page 3
Page 4
4. Intangible Assets
Other
£
Cost
As at 1 January 2024 20,668
As at 31 December 2024 20,668
Amortisation
As at 1 January 2024 4,023
Provided during the period 2,864
As at 31 December 2024 6,887
Net Book Value
As at 31 December 2024 13,781
As at 1 January 2024 16,645
5. Stocks
2024 2023
£ £
Stock 51,201 15,435
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 37,261 5,651
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 1,188 -
Other creditors 61,174 19,986
Taxation and social security 23,981 15,194
86,343 35,180
Page 4